A Study of an IDH1m Inhibitor in Participants with IDH1-Mutated Malignancies and Hepatic or Renal Impairment
S095031-218
Phase 1 other active
Quick answer
A Study of an IDH1m Inhibitor in Participants with IDH1-Mutated Malignancies and Hepatic or Renal Impairment for Newly diagnosed and/or previously treated IDH1-mutated malignancies is a Phase 1 program (other) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Newly diagnosed and/or previously treated IDH1-mutated malignancies
- Phase
- Phase 1
- Modality
- other
- Status
- active